Retail Pricing in Refractive SurgeryLower prices have failed to boost market demand.

Since the first FDA approval of refractive surgery in late 1995, there has been a great deal of debate over the pricing issue, and many providers have assumed that price is the key factor in a prospective patient’s decision-making process. Implicit in this assumption is a belief that, the less something costs, the more of it you will sell…

Tags: , , , , , , , , ,

Download the full article